Third-Gen Generic ALK Lung Cancer Inhib

This is Lorlatinib, a type of medicine that stops ALK and ROS1, which are involved in cancer. It’s for people who have lung cancer with a specific change (ALK-positive) and whose other treatments stopped working. It goes after those kinases, ALK and ROS1, to stop cancer cells from growing.

You can get it in two sizes: 25 milligrams and 100 milligrams. They’re like pills that have a coating to make them easier to swallow. You’re supposed to take it once a day.

A hundred milligrams works best, no matter if you’ve eaten or not. These come in bottles, and there are 30 of the tablets in each box.